ITGAM and neoplasm: In the subcutaneous model, we did not find a significant difference in the populations of tumor-associated CD11b+Gr1+ and CD11bhiGr11lo cells between the control groups and the Lm-LLO-CD105A group (Figure 5A and Supplementary Figure S4A).